Alterations in the expression and cellular localization of protein kinase C isozymes ε and θ are associated with insulin resistance in skeletal muscle of the high-fat-fed rat

Diabetes

Volumn 46, Issue 2, 1997, Pages 169-178

  Schmitz Peiffer, Carsten ^a   Browne, Carol L ^a   Oakes, Nicholas D ^a   Watkinson, Allan ^a   Chisholm, Donald J ^a   Kraegen, Edward W ^a   Biden, Trevor J ^a  

^a GARVAN INSTITUTE OF MEDICAL RESEARCH   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

DIACYLGLYCEROL; GLUCOSE; INSULIN; ISOENZYME; PROTEIN KINASE C; TRIACYLGLYCEROL;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; ENZYME ACTIVITY; FAT INTAKE; GLUCOSE BLOOD LEVEL; IMMUNOBLOTTING; INSULIN RESISTANCE; LIPID METABOLISM; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SKELETAL MUSCLE; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 0030914330     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diab.46.2.169     Document Type: Article

References (64)

1. McGarry JD: What if Minkowski had been ageusic? An alternative angle on diabetes. Science 258:766-770, 1992
2. Borkman M, Storlien LH, Pan DA, Jenkins AB, Chisholm DJ, Campbell LV: The relation between insulin sensitivity and the fatty-acid composition of skeletal-muscle phospholipids. N Engl J Med 328:238-244, 1993
3. Storlien LH, Kraegen EW, Chisholm DJ, Ford GL, Bruce DG, Pascoe WS: Fish oil prevents insulin resistance induced by high-fat feeding in rats. Science 237:885-888, 1987
4. Kraegen EW, Clark PW, Jenkins AB, Daley EA, Chisholm DJ, Storlien LH: Development of muscle insulin resistance after liver insulin resistance in high-fat fed rats. Diabetes 40:1397-1403, 1991
5. Kahn CR: Insulin action, diabetogenes, and the cause of type II diabetes. Diabetes 43:1066-1084, 1994
6. Myers MG, White MF: New frontiers in insulin receptor substrate signaling. Trends Endocrinol Metab 6:209-215, 1995
7. Chen KS, Heydrick S, Kurowski T, Ruderman NB: Diacylglycerol-protein kinase C signaling in skeletal muscle: a possible link to insulin resistance. Trans Assoc Am Phys 104:206-212, 1991
8. Shmueli E, Alberti KGM, Record CO: Diacylglycerol protein kinase-C signaling: a mechanism for insulin resistance. J Intern Med 234:397-400, 1993
9. Considine RV, Caro JF: Protein kinase-C: mediator or inhibitor of insulin action. J Cell Biochem 52:8-13, 1993
10. 2+-and phospholipid-activated protein kinase (protein kinase C). J Biol Chem 259:8743-8747, 1984
11. Bollag GE, Roth RA, Beaudoin J, Mochly RD, Koshland DJ: Protein kinase C directly phosphorylates the insulin receptor in vitro and reduces its proteintyrosine kinase activity. Proc Natl Acad Sci USA 83:5822-5824, 1986
12. Haring HU: The insulin receptor signaling mechanism and contribution to the pathogenesis of insulin resistance. Diabetologia 34:848-861, 1991
13. Takayama S, Kahn CR, Kubo K, Foley JE: Alterations in insulin receptor autophosphorylation in insulin resistance: correlation with altered sensitivity to glucose transport and antilipolysis to insulin. J Clin Endocrinol Metab 66:992-999, 1988
14. Caro JF, Jenquin M, Long S: Effects of phorbol esters on insulin receptor function and insulin action in hepatocytes: evidence for heterogeneity. Mol Cell Biochem 109:115-118, 1992
15. Danielsen AG, Liu F, Hosomi Y, Shii K, Roth RA: Activation of protein kinase C alpha inhibits signaling by members of the insulin receptor family. J Biol Chem 270:21600-21605, 1995
16. Anderson CM, Olefsky JM: Phorbol ester-mediated protein kinase-C interaction with wild-type and COOH-terminal truncated insulin receptors. J Biol Chem 266:21760-21764, 1991
17. Seedorf K, Shearman M, Ullrich A: Rapid and long term effects of protein kinase C on receptor tyrosine kinase phosphorylation and degradation. J Biol Chem 270:18953-18960, 1995
18. Nishizuka Y: Protein kinases. V. Protein kinase C and lipid signaling for sustained cellular responses. FASEB J 9:484-496, 1995
19. James DE, Jenkins AB, Kraegen EW: Heterogeneity of insulin action in individual muscles in vivo: euglycemic clamp studies in rats. Am J Physiol 248:E567-E574, 1985
20. Oakes ND, Kennedy CJ, Jenkins AB, Laybutt DR, Chisholm DJ, Kraegen EW: A new antidiabetic agent, BRL 49653, reduces lipid availability and improves insulin action and glucoregulation in the rat. Diabetes 43:1203-1210, 1994
21. Storlien LH, James DE, Burleigh KM, Chisholm DJ, Kraegen EW: Fat feeding causes widespread in vivo insulin resistance, decreased energy expenditure and obesity in the rat. Am J Physiol 251:E576-E583, 1986
22. Kraegen EW, James DE, Bennett SP, Chisholm DJ: In vivo insulin sensitivity in the rat determined by euglycemic clamp. Am J Physiol 245:E1-E7, 1983
23. Kraegen EW, James DE, Jenkins AB, Chisholm DJ: Dose response curves for in vivo insulin sensitivity in individual tissues in rats. Am J Physiol 248:E353-E362, 1985
24. Selbie LA, Schmitz-Peiffer C, Sheng YH, Biden TJ: Molecular cloning and characterization of PKC(iota), an atypical isoform of protein kinase-C derived from insulin-secreting cells. J Biol Chem 268:24296-24302, 1993
25. Laemmli UK: Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-685, 1970
26. Storlien LH, Jenkins AB, Chisholm DJ, Pascoe WS, Khouri D, Kraegen EW: Influence of dietary fat composition on development of insulin resistance in rats. Diabetes 40:280-289, 1991
27. Nakamura K, Handa S: Coomassie brilliant blue staining of lipids on thin-layer plates. Anal Biochem 142:406-410, 1984
28. Heydrick SJ, Ruderman NB, Kurowski TG, Adams HB, Chen KS: Enhanced stimulation of diacylglycerol and lipid synthesis by insulin in denervated muscle: altered protein kinase-C activity and possible link to insulin resistance. Diabetes 40:1707-1711, 1991
29. 2+-and TPA-sensitive PKC in HT-29 human intestinal epithelial cells. FEBS Lett 344:161-165, 1994
30. Allen BG, Andrea JE, Walsh MP: Identification and characterization of protein kinase C ζ-immunoreactive proteins. J Biol Chem 269:29288-29298, 1994
31. Nishizuka Y: Intracellular signaling by hydrolysis of phospholipids and activation of protein kinase-C. Science 258:607-614, 1992
32. Osada S, Mizuno K, Saido TC, Akita Y, Suzuki K, Kuroki T, Ohno S: A phorbol ester receptor/protein kinase, nPKC eta, a new member of the protein kinase C family predominantly expressed in lung and skin. J Biol Chem 265:22434-22440, 1990
33. Nakano S, Shimohama S, Saitoh T, Akiguchi I, Kimura J: Localization of protein kinase-C in human skeletal muscle. Muscle Nerve 15:496-499, 1992
34. Hietanen M, Koistinaho J, Rechardt L, Roivainen R, Pelto HM: Immunohistochemical evidence for the presence of protein kinase C beta-subtype in rat motoneurons and myoneural junctions. Neurosci Lett 115:126-130, 1990
35. Hilgenberg L, Miles K: Developmental regulation of a protein kinase C isoform localized in the neuromuscular junction. J Cell Sci 108:51-61, 1995
36. Yamada K, Avignon A, Standaert ML, Cooper DR, Spencer B, Farese RV: Effects of insulin on the translocation of protein kinase C-theta and other protein kinase C isoforms in rat skeletal muscles. Biochem J 308:177-180, 1995
37. Hong DH, Huan J, Ou BR, Yeh JY, Saido TC, Cheeke PR, Forsberg NE: Protein kinase C isoforms in muscle cells and their regulation by phorbol ester and calpain. Biochim Biophys Acta 1267:45-54, 1995
38. Donnelly R, Reed MJ, Azhar S, Reaven GM: Expression of the major isoenzyme of protein kinase-C in skeletal muscle, nPKC theta, varies with muscle type and in response to fructose-induced insulin resistance. Endocrinology 135:2369-2374, 1994
39. Osada S, Mizuno K, Saido TC, Suzuki K, Kuroki T, Ohno S: A new member of the protein kinase-C family, nPKCtheta, predominantly expressed in skeletal muscle. Mol Cell Biol 12:3930-3938, 1992
40. Chang JD, Xu YP, Raychowdhury MK, Ware JA: Molecular cloning and expression of a cDNA encoding a novel isoenzyme of protein kinase-C (nPKC): a new member of the nPKC family expressed in skeletal muscle, megakaryoblastic cells, and platelets. J Biol Chem 268:14208-14214, 1993
41. Kazanietz MG, Areces LB, Bahador A, Mischak H, Goodnight J, Mushinski JF, Blumberg PM: Characterization of ligand and substrate specificity for the calcium-dependent and calcium-independent protein kinase-C isozymes. Mol Pharmacol 44:298-307, 1993
42. Baier G, Baierbitterlich G, Meller N, Coggeshall KM, Giampa L, Telford D, Isakov N, Altman A: Expression and biochemical characterization of human protein kinase C-theta. Eur Biochem 225:195-203, 1994
43. Cooper DR, Ishizuka T, Watson JE, Standaert, ML, Nair G, Farese RV: Protein kinase C activation patterns are determined by methodological variations: studies of insulin action in BC3H-1 myocytes and rat adipose tissue. Biochim Biophys Acta 1054:95-102, 1990
44. Bastani B, Yang L, Baldassare JJ, Pollo DA, Gardner JD: Cellular distribution of isoforms of protein kinase C (PKC) in pancreatic acini. Biochim Biophys Acta 1269:307-315, 1995
45. Pfeffer LM, Eisenkraft BL, Reich NC, Improta T, Baxter G, Daniel-Issakani S, Strulovici B: Transmembrane signaling by interferon alpha involves diacylglycerol production and activation of the epsilon isoform of protein kinase C in Daudi cells. Proc Natl Acad Sci USA 88:7988-7992, 1991
46. Khan WA, Blobe G, Halpern A, Taylor W, Wetsel WC, Burns D, Loomis C, Hannun YA: Selective regulation of protein kinase-C isoenzymes by oleic acid in human platelets. J Biol Chem 268:5063-5068, 1993
47. Zhao L, Standaert ML, Cooper DR, Avignon A, Farese RV: Effects of insulin on protein kinase-C (PKC) in HIRC-B cells: specific activation of PKC epsilon and its resistance to phorbol ester-induced down-regulation. Endocrinology 135:2504-2510, 1994
48. Wang FS, Naik UP, Ehrlich YH, Osada SI, Ohno S, Kornecki E: Stimulatory antibody-induced activation and selective translocation of protein kinase C isoenzymes in human platelets. Biochem J 311:401-406, 1995
49. Cacace AM, Guadagno SN, Krauss RS, Fabbro D, Weinstein IB: The epsilon isoform of protein kinase-C is an oncogene when overexpressed in rat fibroblasts. Oncogene 8:2095-2104, 1993
50. Mischak H, Goodnight JA, Kolch W, Martiny-Baron G, Schaechtle C, Kazanietz MG, Blumberg PM, Pierce JH, Mushinski JF: Overexpression of protein kinase C-delta and -epsilon in NIH 3T3 cells induces opposite effects on growth, morphology, anchorage dependence, and tumorigenicity. J Biol Chem 268:6090-6096, 1993
51. Huwiler A, Fabbro D, Pfeilschifter J: Differential recovery of protein kinase C-alpha and -epsilon isozymes after long-term phorbol ester treatment in rat renal mesangial cells. Biochem Biophys Res Commun 180:1422-1428, 1991
52. O'Driscoll KR, Teng KK, Fabbro D, Greene LA, Weinstein IB: Selective translocation of protein kinase C-delta in PC12 cells during nerve growth factor-induced neuritogenesis. Mol Biol Cell 6:449-458, 1995
53. 2+-independent protein kinase C isozyme, Npkc epsilon, increases the secretion of prolactin from thyrotropin-releasing hormone-stimulated rat pituitary GH(4)C(1) cells. J Biol Chem 269:4653-4660, 1994
54. Borner C, Guadagno SN, Fabbro D, Weinstein IB: Expression of four protein kinase C isoforms in rat fibroblasts: distinct subcellular distribution and regulation by calcium and phorbol esters. J Biol Chem 267:12892-12899, 1992
55. Jalava A, Lintunen M, Heikkila J: Protein kinase C-alpha but not protein kinase C-epsilon is differentially down-regulated by bryostatin 1 and tetradecanoyl phorbol 13-acetate in SH-SY5Y human neuroblastoroa cells. Biochem Biophys Res Comm 191:472-478, 1993
56. Xia P, Inoguchi T, Kern TS, Engerman RL, Oates PJ, King GL: Characterization of the mechanism for the chronic activation of diacylglycerol-protein kinase C pathway in diabetes and hypergalactosemia. Diabetes 43:1122-1129, 1994
57. Shiba T, Inoguchi T, Sportsman JR, Heath WF, Bursell S, King GL: Correlation of diacylglycerol level and protein kinase-C activity in rat retina to retinal circulation. Am J Physiol 265:E783-E793, 1993
58. Inoguchi T, Battan R, Handler E, Sportsman JR, Heath W, King GL: Preferential elevation of protein kinase C isoform beta II and diacylglycerol levels in the aorta and heart of diabetic rats: differential reversibility to glycemic control by islet cell transplantation. Proc Natl Acad Sci USA 89:11059-11063, 1992
59. Considine RV, Nyce MR, Allen LE, Morales LM, Triester S, Serrano J, Colberg J, Lanzajacoby S, Caro JF: Protein kinase C is increased in the liver of humans and rats with noninsulin-dependent diabetes mellitus: an alteration not due to hyperglycemia. J Clin Invest 95:2938-2944, 1995
60. Graber R, Sumida C, Nimez EA: Fatty acids and cell signal transduction. J Lipid Mediators Cell Signal 9:91-116, 1994
61. Nakamura S, Nishizuka Y: Lipid mediators and protein kinase C activation for the intracellular signaling network. J Biochem Tokyo 115:1029-1034, 1994
62. Stasia MJ, Dianoux AC, Vignais PV: Inhibition of protein kinase C from polymorphonuclear neutrophils by long chain acyl coenzyme A and counteraction by Mg-ATP. Biochem Biophys Res Comm 147:428-436, 1987
63. Bronfman M, Orellana A, Morales MN, Bieri F, Waechter F, Staubli W, Bentley P: Potentiation of diacylglycerol-activated protein kinase C by acyl-coenzyme A thioesters of hypolipidaemic drugs. Biochem Biophys Res Comm 159:1026-1031, 1989
64. Majumdar S, Rossi MW, Fujiki T, Phillips WA, Disa S, Queen CF, Johnston RJ, Rosen OM, Corkey BE, Korchak HM: Protein kinase C isotypes and signaling in neutrophils: differential substrate specificities of a translocatable calcium-and phospholipid-dependent beta-protein kinase C and aphospholipid-dependent protein kinase which is inhibited by long chain fatty acyl coenzyme A. J Biol Chem 266:9285-9294, 1991